Colin Granger

Title: Colin Granger: Innovator in Cholinergic Agents

Introduction

Colin Granger is a notable inventor based in Costa Mesa, CA (US). He has made significant contributions to the field of pharmacology, particularly in the development of cholinergic agents. His innovative work focuses on the treatment of various medical conditions through the use of complex compounds.

Latest Patents

Colin Granger holds a patent for "Multivalent salts of pyridostigmine and related compounds." This invention involves a quaternary ammonium cholinergic agent that is complexed with a multivalent anion or multiple monovalent anions. The complex can be administered orally to treat pain or for other therapeutic purposes. The patent contemplates numerous modifications, including changes to the ring structure of the compound and the use of different anions, both organic and inorganic. These compounds have utility as cholinergic agents, particularly in treating myasthenia gravis, chest pain, and carpal tunnel syndrome. He has 1 patent to his name.

Career Highlights

Colin Granger is currently associated with Icn Pharmaceuticals, Inc., where he continues to innovate in the field of pharmaceuticals. His work has the potential to impact the treatment of various neuromuscular disorders significantly.

Collaborations

Colin collaborates with esteemed colleagues, including Robert Orr and Kandasamy Ramasamy. Their combined expertise enhances the research and development efforts at Icn Pharmaceuticals, Inc.

Conclusion

Colin Granger's contributions to the field of cholinergic agents exemplify the importance of innovation in medicine. His patent for multivalent salts of pyridostigmine showcases his commitment to improving patient care through advanced pharmacological solutions.